| 证券代码：688059 | 证券简称：华锐精密 | 公告编号：2026-011 | | --- | --- | --- | | 转债代码：118009 | 转债简称：华锐转债 | | 株洲华锐精密工具股份有限公司 关于持股 5%以上的股东权益变动触及 1%刻度的提 示性公告 投资者保证向本公司提供的信息真实、准确、完整，没有虚假记载、误导性陈述或 重大遗漏。 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： 二、权益变动触及 1%刻度的基本情况 自2026年1月16日至2026年1月22日期间，"华锐转债"累计转股2,918,547 股，株洲华锐精密工具股份有限公司（以下简称"公司"）总股本由 95,324,869 股 增加至 98,243,416 股。公司实际控制人及其一致行动人因公司总股本增加，其持 | 股比例由 | | --- | | 41.92%被动稀释至 | | 40.67%，权益变动触及 1%刻度。 | | | | 变动前股 | 变动前 | 变动后股 | 变动后 | | 权益变动 | 资金来 | | --- | --- | --- | --- | --- | ...

| 证券代码：688059 | 证券简称：华锐精密 | 公告编号：2026-012 | | --- | --- | --- | | 转债代码：118009 | 转债简称：华锐转债 | | 株洲华锐精密工具股份有限公司 关于实施"华锐转债"赎回暨摘牌的第五次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 截至 2026 年 1 月 23 日收市后，距离 2026 年 1 月 28 日（"华锐转债"最后 交易日）仅剩 3 个交易日，2026 年 1 月 28 日为"华锐转债"最后一个交易日。 最后转股日：2026 年 2 月 2 日 截至 2026 年 1 月 23 日收市后，距离 2026 年 2 月 2 日（"华锐转债"最后 转股日）仅剩 6 个交易日，2026 年 2 月 2 日为"华锐转债"最后一个转股日。 本次提前赎回完成后，"华锐转债"将自 2026 年 2 月 3 日起在上海证券 交易所摘牌。 投资者所持可转债除在规定时限内通过二级市场继续交易或按照 61.89 元/股的转股价格进行转 ...

Core Viewpoint - The announcement from Huari Precision indicates a significant increase in the company's total share capital due to the conversion of bonds into shares, resulting in a dilution of the controlling shareholders' stake without triggering a mandatory takeover bid [1] Group 1: Share Capital Changes - From January 16 to January 22, 2026, a total of 2.918547 million shares were converted from "Huari Convertible Bonds," increasing the company's total share capital from 95.324869 million shares to 98.243416 million shares [1] - The controlling shareholders, including Xiao Xukai and Wang Yuqin, experienced a dilution in their ownership percentage from 41.92% to 40.67% due to the increase in total share capital [1] Group 2: Future Disclosures - The company will provide timely disclosures regarding any future changes in equity as the "Huari Convertible Bonds" remain in the conversion period [1]

Investment Rating - The report assigns a "Buy-A" rating to the company with a 6-month target price of 126.87 CNY, corresponding to a 40x PE for 2026 [2][3]. Core Insights - The company is expected to achieve a net profit of 180-200 million CNY in 2025, representing a year-on-year increase of 68.29%-86.99% [1]. - The anticipated revenue for 2025-2027 is projected to be 1.05 billion, 1.26 billion, and 1.45 billion CNY, with year-on-year growth rates of 38.3%, 20.0%, and 14.7% respectively [2]. - The company is actively exploring new opportunities in AI software, enhancing its product offerings and operational efficiency [1]. Financial Performance Summary - The company's revenue for 2025 is estimated at 1,050 million CNY, with a net profit of 188 million CNY, reflecting a net profit margin of 17.9% [3][6]. - The projected net profit for 2026 is 302 million CNY, with a net profit margin increasing to 24.0% [3][6]. - The earnings per share (EPS) for 2025 is expected to be 1.98 CNY, increasing to 3.17 CNY in 2026 [3][6]. Market Position and Strategy - The company is positioned as a leading domestic player in the tool manufacturing sector, likely to see an increase in market share and profitability as manufacturing demand stabilizes [2]. - The introduction of the "HuaRui Smart Plus" industrial software is expected to enhance processing efficiency by 5-30%, thereby optimizing management costs and extending tool lifespan [1].

Investment Rating - The report maintains a "Buy" rating for the company, indicating a positive outlook for its stock performance in the coming months [3][8][12]. Core Views - The company is expected to achieve significant growth in 2025, with a projected net profit of 1.80 to 2.00 billion yuan, representing a year-on-year increase of 68.29% to 86.99% [5]. - The growth is attributed to three main factors: recovery in downstream demand, price increases due to rising raw material costs, and improved operational efficiency leading to lower expense ratios [5][6]. - The company is well-positioned to benefit from industry consolidation and domestic substitution trends, particularly in the context of high tungsten carbide prices [6][7]. - The introduction of AI industrial software is expected to create a second growth curve for the company, enhancing its profitability and operational efficiency [7][8]. Financial Summary - The company forecasts revenue growth from 759 million yuan in 2024 to 2.25 billion yuan in 2027, with a compound annual growth rate (CAGR) of approximately 60% from 2025 to 2026 [3][10]. - The projected net profit for 2025 is estimated at 210 million yuan, with a significant increase to 552 million yuan by 2027 [3][10]. - The price-to-earnings (P/E) ratio is expected to decrease from 44.3 in 2025 to 16.9 in 2027, indicating improving valuation metrics as earnings grow [3][10].

证券代码：688059 证券简称：华锐精密 公告编号：2026-010 转债代码：118009 转债简称：华锐转债 株洲华锐精密工具股份有限公司 2025年年度业绩预告 一、本期业绩预告情况 （一）业绩预告期间 2025年1月1日至2025年12月31日 （二）业绩预告情况 1、经财务部门初步测算，株洲华锐精密工具股份有限公司（以下简称"公司"）预计2025年度实现归属 于母公司所有者的净利润为18,000.00万元到20,000.00万元，与上年同期相比，将增加7,304.09万元到 9,304.09万元，同比增加68.29%到86.99%。 2、预计2025年度实现归属于母公司所有者的扣除非经常性损益的净利润为17,800.00万元到19,800.00万 元，与上年同期相比，将增加7,368.95万元到9,368.95万元，同比增加70.64%到89.82%。 3、本次业绩预告未经注册会计师审计。 二、上年同期业绩情况与财务状况 （一）利润总额：12,010.24万元。归属于母公司所有者的净利润：10,695.91万元。归属于母公司所有者 的扣除非经常性损益的净利润：10,431.05万元。 （二）每股收 ...

Group 1: Company Fundraising and Investment - Company plans to use 500 million yuan of raised funds to increase capital in its wholly-owned subsidiaries for the implementation of a DRAM investment project [1] - Zhuhai Hengqin Chip Storage Co., Ltd. will receive 30 million yuan, and Hefei Chip Storage Co., Ltd. and Xi'an Chip Storage Co., Ltd. will receive 50 million yuan and 30 million yuan respectively for the DRAM project [1] Group 2: Profit Forecasts and Turnarounds - Yiling Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan in 2025, recovering from a loss of 725 million yuan in the previous year [2] - Liard anticipates a net profit of 300 million to 380 million yuan in 2025, compared to a loss of 889 million yuan last year, driven by a new strategic cycle focusing on AI [2] - Daming City forecasts a net profit of 140 million to 165 million yuan in 2025, recovering from a loss in the previous year, aided by reduced asset impairment losses [3] - Guanghua Technology expects a net profit of 85 million to 120 million yuan in 2025, recovering from a loss of 205 million yuan last year, due to expansion in specialized chemicals and PCB sectors [3] - Boteng Co. anticipates a net profit of 80 million to 105 million yuan in 2025, recovering from a loss of 288 million yuan, supported by operational efficiency improvements [4] - Shiyida expects a net profit of 31 million to 46 million yuan in 2025, recovering from a loss of 2.34 million yuan last year, driven by business development and cost control [4] - Guochuang High-tech forecasts a net profit of 16 million to 24 million yuan in 2025, recovering from a loss of 49 million yuan, aided by improved receivables management [5][6] Group 3: Share Buybacks - Hengyi Petrochemical plans to repurchase shares with a total fund of no less than 500 million yuan and no more than 1 billion yuan, with a maximum price of 15 yuan per share [7] - Yunyi Electric plans to repurchase shares with a total fund of no less than 100 million yuan and no more than 150 million yuan, with a maximum price of 17 yuan per share [7] - Xidian Pharmaceutical intends to repurchase shares with a total fund of no less than 25 million yuan and no more than 50 million yuan, with a maximum price of 42 yuan per share [7] Group 4: Performance Highlights - Te Yi Pharmaceutical expects a net profit of 70 million to 90 million yuan in 2025, a growth of 241.55% to 339.13% year-on-year [8] - Xingqi Eye Medicine anticipates a net profit of 662 million to 749 million yuan in 2025, a growth of 95.82% to 121.56% year-on-year [8] - Tianhe Co. forecasts a net profit of 41 million to 60 million yuan in 2025, a growth of 84.35% to 169.78% year-on-year [8] - Ruichuang Micro-Nano expects a net profit of approximately 1.1 billion yuan in 2025, a 93% increase year-on-year [9] - Zhongyuan Co. anticipates a net profit of 139 million to 158 million yuan in 2025, a growth of 80% to 105% year-on-year [9] Group 5: Important Corporate Developments - Aolaide has received acceptance for its application to issue securities on the Science and Technology Innovation Board [14] - *ST Songfa's subsidiary signed contracts for the construction of two VLCC super-large oil tankers, expected to positively impact future performance [15] - Chongda Technology's subsidiary signed an investment agreement for a 1 billion yuan IC packaging project in Jiangsu Province [15] - Yinglian Co. signed a strategic agreement with LG Chem to establish a joint laboratory for innovative materials in lithium battery applications [16]

Group 1 - ShenNan Electric A expects a net profit increase of 584.66%-721.59% year-on-year for 2025 [1] - Te Yi Pharmaceutical anticipates a net profit increase of 241.55%-339.13% year-on-year for 2025 [1] - RunTu Co. forecasts a net profit increase of 181.05%-227.89% year-on-year for 2025 [1] - QingSong Co. projects a net profit increase of 137.73%-201.74% year-on-year for 2025 [1] - RuiSheng Intelligent expects a net profit increase of 112.00%-139.99% year-on-year for 2025 [1] - JianKai Technology anticipates a net profit increase of 101.09%-121.20% year-on-year for 2025 [1] - XingQi Eye Medicine forecasts a net profit increase of 95.82%-121.56% year-on-year for 2025 [1] - RuiChuang MicroNano expects a net profit increase of approximately 93% year-on-year for 2025 [1] - TianHe Co. projects a net profit increase of 84.35%-169.78% year-on-year for 2025 [1] - ZhongYuan Co. anticipates a net profit increase of 80%-105% year-on-year for 2025 [1] - YiDao Information expects a net profit increase of 76.04%-128.85% year-on-year for 2025 [1] - ShengDa Bio forecasts a net profit increase of 69.93%-120.90% year-on-year for 2025 [1] - HuaRui Precision anticipates a net profit increase of 68.29%-86.99% year-on-year for 2025 [1] - FangZheng Technology expects a net profit increase of 67.06%-98.14% year-on-year for 2025 [1] - JinLing Hotel projects a net profit increase of 65.37%-90.93% year-on-year for 2025 [1] - QiangYi Co. anticipates a net profit increase of 57.87%-71.17% year-on-year for 2025 [1] - LangBo Technology expects a net profit increase of 57.58%-66.53% year-on-year for 2025 [1] - HuaFeng Measurement and Control forecasts a net profit increase of 46%-78% year-on-year for 2025 [1] - Zhaoyi Innovation anticipates a net profit increase of approximately 46% year-on-year for 2025 [1] - JieChang Drive expects a net profit increase of 40%-55% year-on-year for 2025 [1] - ShengYuan Environmental Protection projects a net profit increase of 31.79%-59.24% year-on-year for 2025 [1] - GuangHa Communication anticipates a net profit increase of 21.83%-31.31% year-on-year for 2025 [1] - MaiHe Co. expects a net profit increase of 19.58%-54.76% year-on-year for 2025 [1] Group 2 - YiLing Pharmaceutical expects a net profit of 1.2 billion to 1.3 billion yuan for 2025, turning profitable year-on-year [1] - LiYade anticipates a net profit of 300 million to 380 million yuan for 2025, turning profitable year-on-year [1] - SiRuiPu expects a net profit of 165 million to 184 million yuan for 2025, turning profitable year-on-year [1] - DaMing City anticipates a net profit of 140 million to 165 million yuan for 2025, turning profitable year-on-year [1] - DaHeng Technology expects a net profit of 106 million yuan for 2025, turning profitable year-on-year [1] - GuangHua Technology projects a net profit of 85 million to 120 million yuan for 2025, turning profitable year-on-year [1] - BoTeng Co. expects a net profit of 80 million to 105 million yuan for 2025, turning profitable year-on-year [2] - ZhongBing HongJian anticipates a net profit of 34 million to 46 million yuan for 2025, turning profitable year-on-year [2]

（编辑 楚丽君） 证券日报网讯 1月22日，华锐精密发布公告称，投资者所持可转债除在规定时限内通过二级市场继续交 易或按照 61.89元/股的转股价格进行转股外，仅能选择以 100 元/张的票面价格加当期应计利息（即 101.1047 元/张）被强制赎回。若被强制赎回，可能面临较大投资损失。 ...

证券日报网讯1月22日，华锐精密发布公告称，经财务部门初步测算，株洲华锐精密工具股份有限公司 (以下简称"公司")预计2025年度实现归属于母公司所有者的净利润为18，000.00万元到20，000.00万 元，与上年同期相比，将增加7，304.09万元到9，304.09万元，同比增加68.29%到86.99%。 ...